Compare Cipla with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs DIVIS LABORATORIES - Comparison Results

CIPLA     Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA DIVIS LABORATORIES CIPLA/
DIVIS LABORATORIES
 
P/E (TTM) x 24.7 32.7 75.3% View Chart
P/BV x 2.5 7.4 34.1% View Chart
Dividend Yield % 0.6 0.6 104.9%  

Financials

 CIPLA   DIVIS LABORATORIES
EQUITY SHARE DATA
    CIPLA
Mar-19
DIVIS LABORATORIES
Mar-18
CIPLA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs6781,142 59.4%   
Low Rs484533 90.8%   
Sales per share (Unadj.) Rs198.2146.6 135.2%  
Earnings per share (Unadj.) Rs18.533.0 56.1%  
Cash flow per share (Unadj.) Rs35.038.4 91.1%  
Dividends per share (Unadj.) Rs3.0010.00 30.0%  
Dividend yield (eoy) %0.51.2 43.2%  
Book value per share (Unadj.) Rs186.3222.8 83.6%  
Shares outstanding (eoy) m805.70265.47 303.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.95.7 51.3%   
Avg P/E ratio x31.425.3 123.7%  
P/CF ratio (eoy) x16.621.8 76.1%  
Price / Book Value ratio x3.13.8 83.0%  
Dividend payout %16.230.3 53.5%   
Avg Mkt Cap Rs m468,031222,318 210.5%   
No. of employees `00022.610.8 210.4%   
Total wages/salary Rs m28,5654,561 626.3%   
Avg. sales/employee Rs Th7,053.13,616.0 195.1%   
Avg. wages/employee Rs Th1,261.5423.8 297.7%   
Avg. net profit/employee Rs Th659.1814.9 80.9%   
INCOME DATA
Net Sales Rs m159,71038,915 410.4%  
Other income Rs m4,7661,134 420.1%   
Total revenues Rs m164,47540,049 410.7%   
Gross profit Rs m30,97312,617 245.5%  
Depreciation Rs m13,2631,425 930.8%   
Interest Rs m1,68413 12,663.9%   
Profit before tax Rs m20,79112,313 168.9%   
Minority Interest Rs m-1720-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,6953,543 160.7%   
Profit after tax Rs m14,9248,770 170.2%  
Gross profit margin %19.432.4 59.8%  
Effective tax rate %27.428.8 95.2%   
Net profit margin %9.322.5 41.5%  
BALANCE SHEET DATA
Current assets Rs m124,26645,351 274.0%   
Current liabilities Rs m37,7156,507 579.6%   
Net working cap to sales %54.299.8 54.3%  
Current ratio x3.37.0 47.3%  
Inventory Days Days91127 71.5%  
Debtors Days Days9595 99.7%  
Net fixed assets Rs m105,19021,160 497.1%   
Share capital Rs m1,611531 303.5%   
"Free" reserves Rs m148,51158,625 253.3%   
Net worth Rs m150,12359,156 253.8%   
Long term debt Rs m38,3010-   
Total assets Rs m239,63367,832 353.3%  
Interest coverage x13.3926.8 1.4%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.70.6 116.2%   
Return on assets %6.912.9 53.5%  
Return on equity %9.914.8 67.1%  
Return on capital %11.820.8 56.8%  
Exports to sales %34.70-   
Imports to sales %021.8 0.0%   
Exports (fob) Rs m55,419NA-   
Imports (cif) Rs mNA8,485 0.0%   
Fx inflow Rs m57,41032,359 177.4%   
Fx outflow Rs m19,0419,042 210.6%   
Net fx Rs m38,36823,317 164.6%   
CASH FLOW
From Operations Rs m16,9117,759 218.0%  
From Investments Rs m-16,687-4,783 348.9%  
From Financial Activity Rs m-3,487-3,142 111.0%  
Net Cashflow Rs m-3,451-166 2,079.0%  

Share Holding

Indian Promoters % 16.0 52.0 30.8%  
Foreign collaborators % 20.8 0.0 -  
Indian inst/Mut Fund % 12.2 11.8 103.4%  
FIIs % 23.7 19.0 124.7%  
ADR/GDR % 1.1 0.0 -  
Free float % 26.2 17.2 152.3%  
Shareholders   161,166 31,796 506.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  ELDER PHARMA  SUVEN LIFESCIENCES  

Compare CIPLA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY20); Net Profit Up 5.6% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CIPLA has posted a net profit of Rs 5 bn (up 5.6% YoY). Sales on the other hand came in at Rs 40 bn (up 1.3% YoY). Read on for a complete analysis of CIPLA's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

CIPLA Announces Quarterly Results (4QFY19); Net Profit Up 144.0% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, CIPLA has posted a net profit of Rs 4 bn (up 144.0% YoY). Sales on the other hand came in at Rs 44 bn (up 19.1% YoY). Read on for a complete analysis of CIPLA's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Sep 16, 2019 (Close)

TRACK CIPLA

COMPARE CIPLA WITH

MARKET STATS